1. Home
  2. IIIV vs ASMB Comparison

IIIV vs ASMB Comparison

Compare IIIV & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo i3 Verticals Inc.

IIIV

i3 Verticals Inc.

HOLD

Current Price

$21.00

Market Cap

489.2M

Sector

Technology

ML Signal

HOLD

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$29.34

Market Cap

440.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IIIV
ASMB
Founded
2012
2005
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
489.2M
440.0M
IPO Year
2018
2010

Fundamental Metrics

Financial Performance
Metric
IIIV
ASMB
Price
$21.00
$29.34
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
5
Target Price
$33.20
$44.20
AVG Volume (30 Days)
281.8K
78.6K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
91.78
EPS
0.02
N/A
Revenue
N/A
N/A
Revenue This Year
$9.05
N/A
Revenue Next Year
$8.07
$235.63
P/E Ratio
$1,052.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$19.89
$9.82
52 Week High
$33.97
$39.71

Technical Indicators

Market Signals
Indicator
IIIV
ASMB
Relative Strength Index (RSI) 38.37 53.18
Support Level N/A $29.31
Resistance Level $23.65 $30.54
Average True Range (ATR) 0.93 1.41
MACD -0.14 0.11
Stochastic Oscillator 23.43 70.11

Price Performance

Historical Comparison
IIIV
ASMB

About IIIV i3 Verticals Inc.

i3 Verticals Inc provides mission-critical enterprise software solutions to public sector entities. These comprehensive cloud-native solutions address a broad range of government functions, including courts and public safety, public administration, utilities, transportation and schools. The company generates the majority of revenue from software and related services, including the sale of subscriptions, recurring services, ongoing support, licenses, and installation and implementation services specific to software.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

Share on Social Networks: